Shenzhen New Industries Biomedical Engineering Co., Ltd.

SZSE:300832 Stock Report

Market Cap: CN¥48.6b

Shenzhen New Industries Biomedical Engineering Past Earnings Performance

Past criteria checks 4/6

Shenzhen New Industries Biomedical Engineering has been growing earnings at an average annual rate of 19.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 19.5% per year. Shenzhen New Industries Biomedical Engineering's return on equity is 22.8%, and it has net margins of 41.7%.

Key information

19.4%

Earnings growth rate

17.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate19.5%
Return on equity22.8%
Net Margin41.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)

Nov 17
Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)

Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?

Oct 14
Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Aug 25
Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Jul 01
A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

Apr 09
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Mar 18
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Mar 01
Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Revenue & Expenses Breakdown

How Shenzhen New Industries Biomedical Engineering makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300832 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,4361,851795422
30 Jun 244,2751,807761398
31 Mar 244,0751,725794384
31 Dec 233,9301,654747366
30 Sep 233,6581,590608366
30 Jun 233,4951,508582357
31 Mar 233,1801,375490342
01 Jan 233,0471,328478318
30 Sep 222,9481,233507296
30 Jun 222,7371,115495262
31 Mar 222,7561,114505233
01 Jan 222,545974530215
30 Sep 212,518906626180
30 Jun 212,451892634155
31 Mar 212,439997603163
31 Dec 202,195939515151
30 Sep 202,065911484147
30 Jun 201,911910427143
31 Mar 201,655745397120
31 Dec 191,682773393119
31 Dec 181,38469430684
31 Dec 171,14153824356
31 Dec 169234522460
30 Sep 168673802760
30 Jun 168113073060
31 Mar 167712782990
31 Dec 157322492920
30 Sep 156772642260
30 Jun 156232791600
31 Mar 155842661490
31 Dec 145452531380
30 Sep 145062241340
30 Jun 144671941300
31 Mar 144231681200
31 Dec 133781411100

Quality Earnings: 300832 has high quality earnings.

Growing Profit Margin: 300832's current net profit margins (41.7%) are lower than last year (43.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300832's earnings have grown by 19.4% per year over the past 5 years.

Accelerating Growth: 300832's earnings growth over the past year (16.4%) is below its 5-year average (19.4% per year).

Earnings vs Industry: 300832 earnings growth over the past year (16.4%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 300832's Return on Equity (22.8%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies